Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Upregulation of the proto-oncogene Bmi-1 predicts a poor prognosis in pediatric acute lymphoblastic leukemia

Fig. 1

Bmi-1 expression was increased in the pediatric ALL clinical specimens. The qRT-PCR assay was repeated three times and produced similar results for each replicate. The Bmi-1 levels are presented as the means ± standard deviation (M ± SD) and were normalized to the GAPDH levels. a The average expression levels of Bmi-1 in pediatric ALL patients (n = 85) versus normal control subjects (n = 18). b The average expression levels of Bmi-1 before and after therapy (n = 19) in the paired samples from pediatric ALL patients. ***P < 0.001; *P < 0.05. CR, complete remission

Back to article page